Longitudinal Associations Between Smoking Cessation Medications and Alcohol Consumption Among Smokers in the International Tobacco Control Four Country Survey

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 5, 2013, Pages 804-810

  Mckee, Sherry A ^a   Young Wolff, Kelly C ^a   Harrison, Emily L R ^a   Cummings, K Michael ^b   Borland, Ron ^c   Kahler, Christopher W ^d   Fong, Geoffrey T ^e,f   Hyland, Andrew ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF WATERLOO   (Canada)

^f ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

Alcohol; Epidemiological; Longitudinal; Nicotine Replacement; Smoking Cessation; Varenicline

Indexed keywords

VARENICLINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; CANADA; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; HEALTH BEHAVIOR; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKING; SMOKING CESSATION; TELEPHONE; UNITED KINGDOM; UNITED STATES;

ADULT; ALCOHOL DRINKING; BENZAZEPINES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NICOTINIC AGONISTS; QUINOXALINES; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS;

NICOTIANA TABACUM;

EID: 84876796135     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12041     Document Type: Article

References (51)

1. Acheson A, Mahler SV, Chi H, de Wit H (2006) Differential effects of nicotine on alcohol consumption in men and women. Psychopharmacology 186:54-63.
2. Augustson EM, Wanke KL, Rogers S, Bergen AW, Chatterjee N, Synder K, Albanes D, Taylor PR, Caporaso NE (2008) Predictors of sustained smoking cessation: a prospective analysis of chronic smokers form the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Public Health 98:549-555.
3. Blomqvist O, Ericson M, Johnson DH, Engel JA, Soderpalm B (1996) Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol 314:257-267.
4. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:3282-3287.
5. Cahill K, Stead LF, Lancaster T (2012) Nicotine receptor partial agonists for smoking cessation. Cocrane Database Syst Rev 4: CD006103.
6. Childs E, Roche DJO, King AC, de Wit H (2012) Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res 36:906-914.
7. Clark A, Lindgren S, Brooks SP, Watson WP, Little HJ (2001) Chronic infusion of nicotine can increase operant self-administration of alcohol. Neuropharmacology 41:108-117.
8. Dani JA, Harris RA (2005) Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 8:1465-1470.
9. Davis TJ, de Fiebre CM (2006) Alcohol's actions on neuronal nicotinic acetylcholine receptors. Alcohol Res Health 29:179-185.
10. Dollar KM, Homish GG, Kozlowski LT, Leonard KE (2009) Spousal and alcohol-related predictors of smoking cessation: a longitudinal study in a community sample of married couples. Am J Public Health 99:231-233.
11. Ericson M, Blomqvist O, Engel JA, Söderpalm B (1998) Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol 358:189-196.
12. Ericson M, Löf E, Stomberg R, Söderpalm B (2009) The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. J Pharmacol Exp Ther 329:225-230.
13. Fong GT, Cummings KM, Borland R, Hastings G, Hyland A, Giovino GA, Hammond D, Thompson ME (2006) The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control 15:iii3-iii11.
14. Fucito LM, Toll BA, Wu R, Romano DM, Tek E, O'Malley SS (2011) A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology 215:655-663.
15. Gonzales RA, Weiss F (1998) Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 18:10663-10671.
16. Gordon T, Doyle JT (1986) Alcohol consumption and its relationship to smoking, weight, blood pressure, and blood lipids. The Albany Study. Arch Intern Med 146:262-265.
17. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry 61:1107-1115.
18. Grucza RA, Beirut LJ (2007) Co-occurring risk factors for alcohol dependence and habitual smoking: update on findings from the Collaborative Study on the Genetics of Alcoholism. Alcohol Res Health 29:172-177.
19. Gunnell D, Irvine D, Wise L, Davies C, Martin RM (2009) Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ 339:b3805.
20. Hammond D, Reid JL, Driezen P, Cummings KM, Borland R, Fong GT, McNeill A (2008) Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey. Addiction 103:1696-1703.
21. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J (1989) Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 84:791-799.
22. Huang Y, Britton J, Hubbard R, Lewis S (in press) Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database. Tob Control [Epub ahead of print].
23. Humfleet G, Munoz R, Sees K, Reus V, Hall S (1999) History of alcohol or drug problems, current use of alcohol or marijuana, and success in quitting smoking. Addict Behav 24:149-154.
24. Kahler CW, Borland R, Hyland A, McKee SA, O'Connor RJ, Fong GT, Cummings KM (2010) Quitting smoking and change in alcohol consumption in the International Tobacco Control (ITC) Four Country Survey. Drug Alcohol Depend 110:101-107.
25. Kahler CW, Borland R, Hyland A, McKee SA, Thompson ME, Cummings KM (2009) Alcohol consumption and quitting smoking in the International Tobacco Control (ITC) Four Country Survey. Drug Alcohol Depend 100:214-220.
26. Kamens HM, Andersen J, Picciotto MR (2010) Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. Psychopharmacology 208:613-626.
27. Kasliwal R, Wilton LV, Shakir SA (2009) Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study. Drug Saf 32:499-507.
28. Katner SN, McBride WJ, Lumeng L, Li T-K, Murphy JM (1997) Involvement of CNS cholinergic systems in alcohol drinking of P rats. Addict Biol 2:215-233.
29. Klatsky AL, Armstrong MA (1992) Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 136:1248-1257.
30. Kouri EM, McCarthy EM, Faust AH, Lukas SE (2004) Pretreatment with transdermal nicotine enhances some of ethanol's acute effects in men. Drug Alcohol Depend 75:55-65.
31. Larsson A, Engel JA (2004) Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev 27:713-720.
32. Lê AD, Wang A, Harding S, Juzytsch W, Shaham Y (2003) Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats. Psychopharmacology 168:216-222.
33. Marrero JA, Fontana RJ, Fu S (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218-224.
34. McKee SA, Falba T, O'Malley SS, Sindelar J, O'Connor PG (2007) Smoking status as a clinical indicator for alcohol misuse in US adults. Arch Intern Med 167:716-721.
35. McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E (2009) Varenicline reduces alcohol self-administration in heavy drinking smokers. Biol Psychiatry 66:185-190.
36. McKee SA, Krishnan-Sarin S, Shi J, Mase T, O'Malley SM (2006) Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology 189:201-210.
37. McKee SA, O'Malley SS, Shi J, Mase T, Krishnan-Sarin S (2008) Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration. Psychopharmacology 196:189-200.
38. Middaugh LD, Szumlinski KK, van Patten Y, Marlow A-L, Kalivas PW (2003) Chronic ethanol consumption by C57BL/6 mice alters the behavioral and neurochemical effects of ethanol: blockade by naltrexone. Alcohol Clin Exp Res 27:1892-1900.
39. Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL (2012) Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology (Berl) 223:299-306.
40. Nadel R, Chappell Am, Samson HH (1998) Effects of nicotine and mecamylamine microinjections into the nucleus accumbens on ethanol and sucrose self-administration. Alcohol Clin Exp Res 22:1190-1198.
41. National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2003) Task Force on Recommended Alcohol Questions - National Council on Alcohol Abuse and Alcoholism Recommended Sets of Alcohol Consumption Questions - October 15-16, 2003. NIAAA. Available at: http://www.webcitation.org/62MB2ygpV. (Accessed October 11, 2007).
42. Nothwehr F, Lando HA, Bobo JK (1995) Alcohol and tobacco use in the Minnesota Heart Health Program. Addict Behav 20:463-470.
43. Pelucchi C, Gallus S, Garavello W (2007) Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health 29:193-198.
44. Perkins KH, Sexton JE, Dimarco A, Grobe J, Scierka A, Stiller RL (1995) Subjective and cardiovascular responses to nicotine combined with alcohol in male and female smokers. Psychopharmacology 119:205-212.
45. Rosengren A, Wilhemsen L, Wedel H (1988) Separate and combined effects of smoking and alcohol abuse in middle-aged men. Acta Med Scand 223:111-118.
46. Smith BR, Horan JT, Gaskin S, Amit Z (1999) Exposure to nicotine enhances acquisition of ethanol drinking by laboratory rats in a limited access paradigm. Psychopharmacology 142:408-412.
47. Söderpalm B, Reicson M, Olausson P, Blomqvist O, Engel JA (2000) Nicotine mechanisms involved in dopaminergic activating and reinforcing properties of ethanol. Behav Brain Res 113:85-96.
48. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, selectivity decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 104:12518-12523.
49. Thompson ME, Fong GT, Hammond D, Boudreau C, Driezen P, Hyland A, Borland R, Cummings KM, Hastings GB, Siahpush M, Mackintosh AM, Laux FL (2006) Methods of the International Tobacco Control (ITC) Four Country Survey. Tob Control 15:iii12-iii18.
50. Tonstad S, Davies S, Flammer M, Russ C, Hughes J (2010) Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis. Drug Saf 33:289-301.
51. Vaillant GE, Schnurr PP, Baron JA (1991) A prospective study of the effects of cigarette smoking and alcohol abuse on mortality. J Gen Intern Med 6:299-304.